Skip to main content
SpringerLink
Log in

β2-Agonists and bronchial hyperresponsiveness

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Bronchial hyperresponsiveness (BHR) is a characteristic feature of asthma, and individuals with this disease respond to a range of physiological and chemical insults that are otherwise innocuous to healthy subjects, suggesting that the mechanisms underlying this phenomenon are characteristic of the asthma phenotype. BHR can be increased following exposure to environmental allergens in suitably sensitized individuals, pollutants, and certain viruses and can also be exacerbated by exposure to certain drugs, including nonsteroidal anti-inflammatory agents and β-blockers. Although β2-agonists administered acutely remain the treatment for the symptoms of asthma, paradoxically, regular treatment with these drugs can result in an increase in BHR, and this has been suggested to contribute to the increase in asthma morbidity and mortality that has been reported by numerous investigators. This article highlights our current understanding of this phenomenon and examines the potential mechanisms responsible for this effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sont, J. K., Willems, L. N., Bel, E. H., van Krieken, J. H., Vandenbroucke, J. P., and Sterk, P. J. (1999), Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am. J. Respir. Crit. Care Med. 159, 1043–1051.

    PubMed  CAS  Google Scholar 

  2. Mithcell, E. A. (1989) Is current treatment increasing asthma mortality and morbidity? Thorax 44, 81–84.

    Google Scholar 

  3. Kelly, H. W. (2005) What is new with the beta2-agonists: issues in the management of asthma. Ann. Pharmacother. 39, 931–938.

    PubMed  CAS  Google Scholar 

  4. Walters, J. A., Wood-Baker, R., and Walters, E. H. (2005), Long-acting beta2-agonists in asthma: an overview of Cochrane systematic reviews. Respir. Med. 99, 384–395.

    PubMed  CAS  Google Scholar 

  5. Stolley P. D. (1972), Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma. Am. Rev. Respir. Dis. 105, 883–890.

    PubMed  CAS  Google Scholar 

  6. Beasley, R., Pearce, N., Crane, J., and Burgess, C. (1999), Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J. Allergy Clin. Immunol. 104, S18-S30.

    PubMed  CAS  Google Scholar 

  7. Abramson M. J., Walters, J., and Walters, E. H. (2003), Adverse effects of beta-agonists: are they clinically relevant? Am J. Respir. Med. 2, 287–297.

    PubMed  CAS  Google Scholar 

  8. Sears, M. R. (2000), Short-acting inhaled beta-agonists: to be taken regularly or as needed? Lancet 355, 1658–1659.

    PubMed  CAS  Google Scholar 

  9. Bond, R. A. (2001), Is paradoxical pharmacology a strategy worth pursuing? Trends Pharmacol Sci. 22, 273–276.

    PubMed  CAS  Google Scholar 

  10. Sterk, P. J. and Bel, E. H. (1989), Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. Eur. Respir. J. 2, 267–274.

    PubMed  CAS  Google Scholar 

  11. Cockcroft, D. W., Killian, D. N., Mellon, J. J. A., and Hargreave, F. E. (1977), Protective effect of drugs on histamine induced asthma. Thorax 32, 429–437.

    PubMed  CAS  Google Scholar 

  12. Sotomayor, H., Badier, M., Vervloet, D., and Orehek, J. (1984), Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen: Reversal by corticosteroids. Am. Rev. Respir. Dis. 130, 56–58.

    PubMed  CAS  Google Scholar 

  13. Cockcroft, D. W. and Murdock, K. Y. (1987), Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J. Allergy Clin. Immunol. 79, 734–740

    PubMed  CAS  Google Scholar 

  14. Laitinen, L. A. and Laitinen, A. (1988), Mucosal inflammation and bronchial hyperreactivity. Eur. Respir J. 1, 488–489.

    PubMed  CAS  Google Scholar 

  15. Avital, A., Springer, C., Bar-Yishay, E., and Godfrey, S. (1995), Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 50, 511–516.

    PubMed  CAS  Google Scholar 

  16. Simonsson, B. G., Skoogh, B. E., Bergh, N. P., Andersson, R., and Svedmyr, N. (1973), In vivo and in vitro effect of bradykinin on bronchial motor tone in normal subjects and patients with airways obstruction. Respiration 30, 378–388.

    PubMed  CAS  Google Scholar 

  17. Fuller, R. W., Dixon, C. M., Cuss, F. M., and Barnes, P. J. (1987), Bradykinin-induced bronchoconstriction in humans.MMode of action. Am. Rev. Respir. Dis. 135, 176–180.

    PubMed  CAS  Google Scholar 

  18. Polosa, R. and Holgate, S. T. (1990), Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am. Rev. Respir. Dis. 142, 1367–1371.

    PubMed  CAS  Google Scholar 

  19. Tan, W. C., Cripps, E., Douglas, N., and Sudlow, M. F. (1982), Protective effect of drugs on bronchroconstriction induced by sulphur dioxide. Thorax 37, 671–676.

    PubMed  CAS  Google Scholar 

  20. Sheppard, D., Wong, W. S., Uehara, C. F., Nadel, J. A., and Boushey, H. A. (1980), Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide. Am. Rev. Respir. Dis. 122, 873–878.

    PubMed  CAS  Google Scholar 

  21. Nichol, G. M., Alton, E. W., Nix, A., Geddes, D. M., Chung, K. F., and Barnes, P. J. (1990), Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstrictionaand nasal potential difference in asthmatic subjects. Am. Rev. Respir. Dis. 142, 576–580.

    PubMed  CAS  Google Scholar 

  22. Wright, W., Zhang, Y. G., Salome, C. M., and Woolcock, A. J. (1990), Effect of inhaled preservatives on asthmatic subjects. I. Sodium metabisulfite. Am. Rev. Respir. Dis. 141, 1400–1404.

    PubMed  CAS  Google Scholar 

  23. Anderson, S. D., Schoeffel, R. E., and Finney, M. (1983), Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma. Thorax 38, 284–291.

    PubMed  CAS  Google Scholar 

  24. Sheppard, D., Rizk, N. W., Boushey, H. A., and Bethel, R. A. (1983), Mechanism of cough and bronchoconstriction induced by distilled water aerosol. Am. Rev. Respir. Dis. 127, 691–694.

    PubMed  CAS  Google Scholar 

  25. Cushley, M. J., Tattersfield, A. E., and Holgate, S. T. (1983), Inhaled a denosine and guanosine on airway resistance in normal and asthmatic subjects. Br. J. Clin. Pharmacol. 15, 161–165.

    PubMed  CAS  Google Scholar 

  26. Basoglu, O. K., Pelleg, A., Essilfie-Quaye, S., Brindicci, C., Barnes, P. J., and Kharitonov, S. A. (2005), Effects of aerosolized adenosine 5′-triphosphate vs adenosine 5′-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma. Chest 128, 1905–1909.

    PubMed  CAS  Google Scholar 

  27. Van den Berge, M., Polosa, R., Kerstjens, H. A., and Postma, D. S. (2004), The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 114, 737–746.

    PubMed  Google Scholar 

  28. Fowler, S. J., Dempsey, Q. J., Sims, E. J., and Lipworth, B. J. (2000), Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype. Am. J. Respir Crit. Care Med. 162, 1318–1322.

    PubMed  CAS  Google Scholar 

  29. Grootendorst, D. C. and Rabe, K. F. (2004), Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 1, 77–87.

    PubMed  CAS  Google Scholar 

  30. Van Schoor, J., Joos, G. F., Pauwels, R. A. (2000), Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clincial research. Eur. Respir. J. 16, 514–533.

    PubMed  Google Scholar 

  31. Van Schoor, J., Pauwels, R., Joos, G. (2005), Indirect bronchial hyper-responsiveness: the coming of age of a specific group of bronchial challenges. Clin. Exp. Allergy 35, 250–261.

    PubMed  Google Scholar 

  32. Marks, G. B., Yates, D. H., Sist, M., et al. (1996), Respiratory sensation during bronchial challenge testing with methacholine, sodium metabisulphite, and adenosine monophosphate. Thorax 51, 793–798.

    PubMed  CAS  Google Scholar 

  33. Rutgers, S. R., ten Hacken, N. H., Koeter, G. H., and Postma, D. S. (2000), Borg scores before and after challenge with adenosine 5′-monophosphate and methacholine in subjects with COPD and asthma. Eur. Respir. J. 16, 486–490.

    PubMed  CAS  Google Scholar 

  34. Berman, A. R., Togias, A. G., Skloot, G., and Proud, D. (1995), Allergen-induced hyperresponsiveness to bradykinin is more pronounced than that to methacholine. J. Appl. Physiol. 78, 1844–1852.

    PubMed  CAS  Google Scholar 

  35. O'Connor, B. J., Crowther, S. D., Costello, J. F., and Morley, J. (1999), Selective airway responsiveness in asthma. Trends Pharmacol. Sci. 20, 9–11.

    PubMed  Google Scholar 

  36. van den Toorn, L. M., Prins, J. B., Overbeek, S. E., Hoogsteden, H. C., and De Jongste, J. C. (2000), Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J. Respir. Crit. Care Med. 162, 953–957.

    Google Scholar 

  37. van den Toorn, L. M., Overbeek, S. E., De Jongste, J. C., Leman, K., Hoogsteden, H. C., and Prins, J. B. (2001), Alrway inflammation is present during clinical remission of atopic asthma. Am J. Respir. Crit. Care Med 164, 2107–2113.

    PubMed  Google Scholar 

  38. Bai, T. R. and Knight, D. A. (2005), Structural changes in the airways in asthma: observations and consequences, Clin. Sci. (Lond.) 108, 463–477.

    Google Scholar 

  39. Fedorov, I. A., Wilson, S. J., Davies, D. E., and Holgate, S. T. (2005), Epithelial stress and structural remodelling in childhood asthma. Thorax 60, 389–394.

    PubMed  CAS  Google Scholar 

  40. Ebina, M., Takahashi, T., Chiba, T., and Motomiya, M. (1993), Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev. Respir Dis. 148, 720–726.

    PubMed  CAS  Google Scholar 

  41. Ma, X., Cheng, Z., Kong, H., et al. (2002), Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L1181-L1189.

    PubMed  CAS  Google Scholar 

  42. Deng, L., Fairbank, N. J., Cole, D. J., Fredberg, J. J., and Maksym, G. N. (2005), Airway smooth muscle tone moudulates mechanically induced cytoskeletal stiffening and remodeling. J. Appl. Physiol. 99, 634–641.

    PubMed  Google Scholar 

  43. Jeffery, P. K. (2004), Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 1, 176–183.

    PubMed  CAS  Google Scholar 

  44. Morley, J. (2005), Inflammation and astham therapy: a false dawn. Pulm. Pharmacol. Ther. 19, 200–204.

    PubMed  Google Scholar 

  45. Robinson, D. S. (2004), The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle? J. Allergy Clin. Immunol 114, 58–65.

    PubMed  CAS  Google Scholar 

  46. Kay, A. B. (2005), The role of eosinophils in the pathogenesis of asthma. Trends Mol. Med. 11, 148–152.

    PubMed  CAS  Google Scholar 

  47. Elias, J. A., Homer, R. J., Hamid, Q., and Lee, C. G. (2005), Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma. J. Allergy Clin. Immunol. 116, 497–500.

    PubMed  CAS  Google Scholar 

  48. Jacoby, D. B., Costello, R. M, and Fryer, A. D. (2001), Eosinophil recruitment to the airway nerves. J. Allergy Clin. Immunol. 107, 211–218.

    PubMed  CAS  Google Scholar 

  49. Minshall, E. M., Leung, D. Y., Martin, R. J., and (1997), Eosinophil-associated TGF-betal mRNA expression and airways fibrosis in bronchial asthma. Am J. Respir. Cell Mol. Biol. 17, 326–333.

    PubMed  CAS  Google Scholar 

  50. Bryan, S. A., O'Connor, B. J., Matti, S., et al. (2000), Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356, 2149–2153.

    PubMed  CAS  Google Scholar 

  51. Leckie, M. J., ten Brinke, A., Khan, J., et al. (2000), Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356, 2144–2148.

    PubMed  CAS  Google Scholar 

  52. De Meer, G., Heederik, D., and Postma, D. S. (2002), Bronchial responsiveness to adenosine 5′-monophosphaate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1). Am. J. Respir. Crit. Care Med. 165, 327–331.

    PubMed  Google Scholar 

  53. Ober, C. and Thompson, E. E. (2005), Rethinking genetic models of asthma: the role of environmental modifiers. Curr. Opin. Immunol. 17, 670–678.

    PubMed  CAS  Google Scholar 

  54. Spina, D. and Page, C. P. (2002), Asthma—a need for a rethink? Trends Pharmacol. Sci. 23, 311–315.

    PubMed  CAS  Google Scholar 

  55. Salpeter, S. R., Ormiston, T. M., and Salpeter, E. E. (2002), Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann. Intern. Med. 137, 715–725.

    PubMed  CAS  Google Scholar 

  56. Szczeklik, A. and Stevenson, D. D. (2003), Aspirininduced asthma: advances in pathogenesis, diagnosis, and management. J. Allergy Clin. Immunol. 111, 913–921.

    PubMed  CAS  Google Scholar 

  57. Mellillo, G., Padovano, A., Masi, C., Melillo, E., and Cocco, G. (1991), Aspirin-induced asthma and bronchial hyperresponsiveness. Allerg. Immunol. (Paris) 23, 423–427.

    Google Scholar 

  58. Vatrella, A., Parrella, R., Pelaia, G., et al. (2001), Effects of non-bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine. Eur. J. Clin. Pharmacol. 57, 99–104.

    PubMed  CAS  Google Scholar 

  59. Mitchell, H. W. and Adcock, J. (1988), Vagal mechanisms and the effect of indomethacin on bronchoconstrictor stimuli in the guinea-pig. Br. J. Pharmacol. 94, 522–527.

    PubMed  CAS  Google Scholar 

  60. Mitchell, H. W. (1988), Inhibitory effect of sodium cromoglycate on pulmonary responses to histamine administered after indomethacin in anaesthetized guinea-pigs, Br. J. Pharmacol. 94, 515–521.

    PubMed  CAS  Google Scholar 

  61. Fryer, A. D. and Okanlami, O. A. (1993), Neuronal M2 muscarinic receptor function in guinea-pig lungs is inhibited by indomethacin. Am. Rev. Respir. Dis. 147, 559–564.

    PubMed  CAS  Google Scholar 

  62. Maclagan, J. and Ney, U. M. (1979), Investigation of the mechanism of propranolol-induced bronchoconstriction. Br. J. Pharmacol. 66, 409–418.

    PubMed  CAS  Google Scholar 

  63. Seeds, E. A., Spina, D., and Page, C. P. (1999), The role of sensory nerves in propranolol-induced bronchial hyperresponsiveness in the guinea-pig. Pulm. Pharmacol. Ther. 12, 27–34.

    PubMed  CAS  Google Scholar 

  64. Speizer, F. E., Doll, R., and Heaf, P (1968), Observations on recent increase in mortality from asthma. BMJ 1, 335–339.

    PubMed  CAS  Google Scholar 

  65. Suissa, S. and Ernst, P. (1997), Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic. J. Clin. Epidemiol. 50, 1079–1088.

    PubMed  CAS  Google Scholar 

  66. Spitzer, W. O., Suissa, S., Ernst, P., et al. (1992), The use of beta-agonists and the risk of death and near death from asthma. N. Engl. J. Med. 326, 501–506.

    Article  PubMed  CAS  Google Scholar 

  67. Suissa, S., Ernst, P., Boivin, J. F., et al. (1994), A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am. J. Respir. Crit. Care Med. 149, 604–610.

    PubMed  CAS  Google Scholar 

  68. Anderson, H. R., Ayres, J. G., Sturdy, P. M., et al. (2005), Bronchodilator treatment and deaths from asthma: case-control study. BMJ 330, 117.

    PubMed  Google Scholar 

  69. Castle, W., Fuller, R., Hall, J., and Palmer, J. (1993), Serevent nationwide surveillance study: Comparison of slameterol with salbutamol in asthmatic patients who require regular brochodilator treatment. Br. Med. J. 306, 1034–1037.

    CAS  Google Scholar 

  70. Lurie, P and Wolfe, S. M. (2005), Misleading data analysis in salmeterol (SMART) study. Lancet 366, 1261–1262.

    PubMed  Google Scholar 

  71. Ernst, P., Spitzer, W. O., Suissa, S., et al. (1992), Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 268, 3462–3464.

    PubMed  CAS  Google Scholar 

  72. Lanes, S. F., Garcia Rodriguez, L. A., and Huerta, C. (2002), Respiratory medications and risk of asthma death. Thorax 57, 683–686.

    PubMed  CAS  Google Scholar 

  73. McIvor, R. A., Pizzichini, E., Turner, M. O., Hussack, P., Hargreave, F. E., and Sears, M. R. (1998), Potential masking effects of salmeterol on airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 158, 924–930.

    PubMed  CAS  Google Scholar 

  74. Lemanske, R. F. Jr., Sorkness, C. A., Mauger, E. A., et al. (2001), Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 285, 2594–2603.

    PubMed  CAS  Google Scholar 

  75. Salpeter, S. R., Buckley, N. S., Ormiston, T. M., and Salpeter, E. E. (2006), Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann. Intern. Med. 144, 904–912.

    PubMed  CAS  Google Scholar 

  76. Harvey, J. E. and Tattersfield, A. E. (1982), Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax 37, 280–287.

    PubMed  CAS  Google Scholar 

  77. Peel, E. T. and Gibson, G. J (1980), Effects of longterm inhaled salbutamol therapy on the provocation of asthma by histamine. Am. Rev. Respir. Dis. 121, 973–978.

    PubMed  CAS  Google Scholar 

  78. Israel, E., Drazen, J. M., Liggett, S. B., et al. (2000), The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J. Respir. Crit. Care Med. 162, 75–80.

    PubMed  CAS  Google Scholar 

  79. Vathenen, A. S., Higgins, B. G., Knox, A. J., Britton, J. R., and Tattersfield, A. E. (1988), Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1, 554–557.

    PubMed  CAS  Google Scholar 

  80. Kraan, J., Koeter, G. H., Van Der Mark, T., Sluiter, H. J., and De Vries, K. (1985), Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline. J. Allergy Clin. Immunol. 76, 628–636.

    PubMed  CAS  Google Scholar 

  81. Kerrebijn, K. F., Essen-Zandvliet, E. E. M., and Neijens, H. J. (1987), Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J. Allergy Clin. Immunol. 79, 653–659.

    PubMed  CAS  Google Scholar 

  82. Raes, M., Mulder, P., and Kerrebijn, K. F. (1989). Long-term effect of ipratropium bromide and fenoterol on the bronchia hy-erresponsiveness to histamine in children with asthma. J. Allergy Clin. Immunol. 84, 874–879.

    PubMed  CAS  Google Scholar 

  83. Van Schayck, C. P., Graafsma, S. J., Visch, M. B., Dompeling, E., Van Weel, C., and Van Herwaarden, C. L. A. (1990), Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 vear is not caused subsensitization to salbutamol. J. Allergy Clin. Immunol. 86, 793–800.

    PubMed  Google Scholar 

  84. Sears, M. R., Taylor, D. R., Print, C. G., et al. (1990), Regular inhaled beta-agonist treatment in bronchial asthama. Lancet 336, 1391–1396.

    PubMed  CAS  Google Scholar 

  85. Waalkens, H. J., Gerritsen, J., Koeter, G. H., Krouwels, F. H., Van Aalderen, W. M. C., and Knol, K. (1991), Budesonide and terbutaline or terbutaline alone in children with mild asthma: Effects on bronchial hyperesponsiveness and diurnal variation in peak flow. Thorax 46, 499–503.

    PubMed  CAS  Google Scholar 

  86. Boulet, L. P., Cartier, A., Thomson, N. C., Roberts, R. S., Dolovich, J., and Hargreave, F. E. (1983), Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J. Allergy Clin. Immunol. 71, 399–406.

    PubMed  CAS  Google Scholar 

  87. Mitchell, E. A. and Jackson, R. T. (1989), Recent trends in asthma mortality, morbidity, and management in New Zealand. Journal of Asthma 26, 349–354.

    PubMed  CAS  Google Scholar 

  88. Cockroft, D. W., McParland, C. P., Britto, S. A., Swystun, V. A., and Rutherford, B. C. (1993), Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342, 833–837.

    Google Scholar 

  89. Prieto, L., Gutierrez, V., Torres, V., Uixera, S., and Marin, J. (2002), Effect of salmeterol on seasonal changes in airway responsiveness and exhaled nitric oxide in pollen-sensitive asthmatic subjects. Chest 122, 798–805.

    PubMed  CAS  Google Scholar 

  90. Taylor, D. R., Town, G. I., Herbison, G. P., et al. (1998). Asthma control during long term treatment with regular inhaled salbutamol and salmeterol. Thorax 53, 744–752.

    PubMed  CAS  Google Scholar 

  91. Kemp, J. P., DeGraff, A. C., Pearlman, D. S., et al. (1999). A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine. J. Allergy Clin. Immunol. 104, 1189–1197.

    PubMed  CAS  Google Scholar 

  92. FitzGerald, J. M., Chapman, K. R., Della, C. G., et al. (1999). Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. J. Allergy Clin. Immunol. 103, 427–435.

    PubMed  CAS  Google Scholar 

  93. Cloosterman, S. G., Bijl-Hofland, I. D., van Herwaarden, C. L., et al. (2001). A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients. Chest 119, 1306–1315.

    PubMed  CAS  Google Scholar 

  94. Bel, E. H., Zwinderman, A. H., Timmers, M. C., Dijkman, J. H., and Sterk, P. J. (1991). The protective effect of beta2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Thorax 46, 9–14.

    PubMed  CAS  Google Scholar 

  95. Wong, A. G., O'Shaughnessy, A. D., Walker, C. M., and Sears, M. R. (1997), Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics. Eur. Respir. J. 10, 330–336.

    PubMed  CAS  Google Scholar 

  96. Sterk, P. J. and Bel, E. H. (1991), The shape of the dose-response curve to inhaled bronchoconstrictor agents in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143, 1433–1437.

    PubMed  CAS  Google Scholar 

  97. Witt-Enderby, P. A., Yamamura, H. I., Halonen, M., Palmer, J. D., and Bloom, J. W. (1993), Chronic exposure to a beta 2-adrenoceptor agonist increases the airway response to methacholine. Eur. J. Pharmacol. 241, 121–123.

    PubMed  CAS  Google Scholar 

  98. Wang, Z. L., Bramley, A. M., McNamara, A., Pare, P. D., and Bai, T. R. (1994), Chronic fenoterol exposure increases in vivo and in vitro airway responses in guinea pigs. Am. J. Respir. Crit. Care Med. 149, 960–965.

    PubMed  CAS  Google Scholar 

  99. Kamachi, A., Munakata, M., Nasuhara, Y., et al. (2001), Enhancement of goblet cell hyperplasia and airway hyperresponsiveness by salbutamol in a rat model of atopic asthma. Thorax 56, 19–54.

    PubMed  CAS  Google Scholar 

  100. Overbeek, S. E., Rijnbeek, P. R., Vons, C., Mulder, P. G. H., Hoogsteden, H. C., and Bogaard, J. M. (1996), Effects of fluticasone propionate on methacholine dose-response curves in nonsmoking atopic asthmatics. Eur. Respir. J. 9, 2256–2262.

    PubMed  Google Scholar 

  101. Page, C. P., Cotter, T., Kilfeather, S., Sullivan, P., Spina, D., and Costello, J. F. (1998), Effect of chronic theophylline treatment on the methacholine dose-response curve in allergic asthmatic subjects. Eur. Respir. J. 12, 24–29.

    PubMed  CAS  Google Scholar 

  102. Cockcroft, D. W., Bhagat, R., Kalra, S., and Swystun, V. A. (1995), Inhaled beta2-agonists and allergen-induced airway responses [1]. J. Allergy Clin. Immunol. 96, 1013,1014.

    Google Scholar 

  103. Cheung, D., Timmers, M. C., Zwinderman, A. H., Bel, E. H., Dijkman, J. H., and Sterk, P. J. (1992), Longterm effects of a long-acting beta2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N. Engl. J. Med. 327, 1198–1203.

    Article  PubMed  CAS  Google Scholar 

  104. Verberne, A. A. P. H. and De Jongste, J. C. (1996), The role of inhaled long-acting bronchodilator therapy. Eur. Respir. Rev. 6, 199–203.

    Google Scholar 

  105. Lipworth, B., Tan, S., Devlin, M., Aiken, T., Baker, R., and Hendrick, D. (1998), Effects of treatment with formoterol on bronchoprotection against methacholine. Am. J. Med. 104, 431–438.

    PubMed  CAS  Google Scholar 

  106. Rabe, K. F., Jorres, R., Nowak, D., Behr, N., and Magnussen, H. (1993), Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am. Rev. Respir. Dis. 147, 1436–1441.

    PubMed  CAS  Google Scholar 

  107. Cockcroft, D. W., Swystun, V. A., and Bhagat, R. (1995), Interaction of inhaled beta2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am. J. Respir. Crit. Care Med. 152, 1485–1489.

    PubMed  CAS  Google Scholar 

  108. Bhagat, R., Swystun, V. A., and Cockcroft, D. W. (1996), Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: Dose response. J. Allergy Clin. Immunol. 97, 47–52.

    PubMed  CAS  Google Scholar 

  109. Giannini, D., Bacci, E., Dente, F. L., et al. (1999). Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge. Chest 115, 629–634.

    PubMed  CAS  Google Scholar 

  110. Cockcroft, D. W., O'Byrne, P. M., Swystun, V. A., and Bhagat, R. (1995), Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J. Allergy Clin. Immunol. 96, 44–49.

    PubMed  CAS  Google Scholar 

  111. Gauvreau, G. M., Jordana, M., Watson, R. M., Cockcroft, D. W., and O'Byrne, P. M. (1997), Effect of regular inhlaed albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am. J. Respir. Crit. Care Med. 156, 1738–1745.

    PubMed  CAS  Google Scholar 

  112. O'Connor, B. J., Aikman, S. L., and Barnes, P. J. (1992), Tolerance to the nonbronchodilator effects of inhaled beta2-agonists in asthma. N. Engl. J. Med. 327, 1204–1208.

    Article  PubMed  Google Scholar 

  113. Yates, D. H., Worsdell, M., and Barnes, P. J. (1998), Effect of inhaled glucocorticosteroid on mast cell and smooth muscle β2 adrenergic tolerance in mild asthma. Thorax 53, 110–113.

    PubMed  CAS  Google Scholar 

  114. Aziz, I., Lipworth, B. J., Dickey, B. F., et al. (1998), Exercise-induced asthma [1] (multiple letters). N. Engl. J. Med. 339, 1783–1786.

    PubMed  CAS  Google Scholar 

  115. Gibson, G. J., Greenacre, J. K., Konig, P., Conolly, M. E., and Pride, N. B. (1978), Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br. J. Dis. Chest 72, 199–206.

    PubMed  CAS  Google Scholar 

  116. Inman, M. D., and O'Byrne, P. M. (1996), The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am. J. Respir. Crit. Care Med. 153, 65–69.

    PubMed  CAS  Google Scholar 

  117. Ramage, L., Lipworth, B. J., Ingram, C. G., Cree, I. A., and Dhillon, D. P. (1994), Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir. Med. 88, 363–368.

    PubMed  CAS  Google Scholar 

  118. Simons, F. E. R. (1997), A comparison of beclomethasone, salmeterol, and placebo in children with asthma. N. Engl. J. Med. 337, 1659–1665.

    PubMed  CAS  Google Scholar 

  119. Nelson, J. A., Strauss, L., Skowronski, M., Ciofo, R., Novak, R., and McFadden, E. R. Jr. (1998), Effect of long-term salmeterol treatment on exercise-induced asthma. N. Engl. J. Med. 339, 141–146.

    PubMed  CAS  Google Scholar 

  120. O'Connor, B. J., Fuller, R. W., and Barnes, P. J. (1994), Nonbronchodilator effects of inhaled beta 2 agonists. Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma. Am. J. Respir. Crit. Care Med. 150, 381–387.

    PubMed  Google Scholar 

  121. Ketchell, R. I., Jensen, M. W., Spina, D., and O'Connor, B. J. (2002), Dose-related effects of formoterol on airway responsiveness to adenosine 5′-monophosphate and histamine. Eur. Respir. J. 19, 611–616.

    PubMed  CAS  Google Scholar 

  122. Soler, M., Joos, L., Bolliger, C. T., Elsasser, S., and Perruchoud, A. P. (1994), Bronchoprotection by salmeterol: Cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction. Eur. Respir. J. 7, 1973–1977.

    PubMed  CAS  Google Scholar 

  123. Taylor, D. A., Jensen, M. W., Aikman, S. L., Harris, J. G., Barnes, P. J., and O'Connor, B. J. (1997), Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. Am. J. Respir. Crit. Care Med. 156, 1731–1737.

    PubMed  CAS  Google Scholar 

  124. Tran, T. M., Friedman, J., Qunaibi, E., Baameuer, F., Moore, R. H., and Clark, R. B. (2004), Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. Mol. Pharmacol. 65, 196–206.

    PubMed  CAS  Google Scholar 

  125. Giannini, D., Carletti, A., Dente, F. L., et al. (1996), Tolerance to the protective effect of salmeterol on allergen challenge. Chest 110, 1452–1457.

    PubMed  CAS  Google Scholar 

  126. Drotar, D. E., Davis, E. E., and Cockcroft, D. W. (1998), Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment. Annals of Allergy 80, 31–34.

    Article  CAS  Google Scholar 

  127. Lee, D. K., Currie, G. P., Hall, I. P., Lima, J. J., and Lipworth, B. J. (2004), The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br. J. Clin. Pharmacol. 57, 68–75.

    PubMed  CAS  Google Scholar 

  128. Taylor, D. R., Drazen, J. M., Herbison, G. P., Yandava, C. N., Hancox, R. J., and Town, G. I. (2000), Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax 55, 762–767.

    PubMed  CAS  Google Scholar 

  129. Israel, E., Chinchilli, V. M., Ford, J. G., et al. (2004), Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 364, 1505–1512.

    PubMed  CAS  Google Scholar 

  130. Small, K. M., McGraw, D. W., and Liggett, S. B. (2003), Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol. 43, 381–411.

    PubMed  CAS  Google Scholar 

  131. Taylor, D. R., Epton, M. J., Kennedy, M. A., et al. (2005), Bronchodilator Response in Relation to β2-Adrenoceptor Haplotype in Patients with Asthma. Am. J. Respir. Crit. Care Med. 172, 700–703.

    PubMed  Google Scholar 

  132. Lee, D. K., Jackson, C. M., Bates, C. E., and Lipworth, B. J. (2004), Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol. Thorax 59, 662–667.

    PubMed  CAS  Google Scholar 

  133. Yates, D. H., Kharitonov, S. A., and Barnes, P. J. (1996), An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta2-agonist. Am. J. Respir. Crit. Care Med. 154, 1603–1607.

    PubMed  CAS  Google Scholar 

  134. Hancox, R. J., Aldridge, R. E., Cowan, J. O., et al. (1999), Tolerance to beta-agonists during acute bronchoconstriction. Eur. Respir. J. 14, 283–287.

    PubMed  CAS  Google Scholar 

  135. Kalra, S., Swystun, V. A., Bhagat, R., and Cockcoft, D. W. (1996), Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 109, 953–956.

    PubMed  CAS  Google Scholar 

  136. Booth, H., Bish, R., Walters, J., Whitehead, F., and Walters, E. H. (1996), Sahneterol tachyphylaxis in steroid treated asthmatic subjects. Thorax 51, 1100–1104.

    PubMed  CAS  Google Scholar 

  137. Tan, K. S., Grove, A., McLean, A., Gnospelius, Y., Hall, I. P., and Lipworth, B. J. (1997), Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic subjects. Am. J. Respir. Crit. Care Med. 156, 28–35.

    PubMed  CAS  Google Scholar 

  138. Aziz, I., and Lipworth, B. J. (1999), Abolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol. Chest 115, 623–628.

    PubMed  CAS  Google Scholar 

  139. Lai, C. K. W., Twentyman, O. P., and Holgate, S. T. (1989), The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occarrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness. Am. Rev. Respir. Dis. 140, 917–923.

    PubMed  CAS  Google Scholar 

  140. Adelroth, E., Rosenhall, L., Johansson, S. A., Linden, M., and Venge, P. (1990), Inflammatory cells and eosinophilic activity in asthmatics investigati-gated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am. Rev. Respir. Dis. 142, 91–99.

    PubMed  CAS  Google Scholar 

  141. Jeffery, P. K., Godfrey, R. W., Adelroth, E., Nelson, A., Rogers, A., and Johansson, S. A. (1992), Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am. Rev. Respir. Dis. 145, 890–899.

    PubMed  CAS  Google Scholar 

  142. Laitinen, L. A., Laitinen, A., and Haahtela, T. (1992), A comparative study of the effects of an inhaled corticosteroid, budesonide and a β2 agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomised double-blind, parallel-group controlled study. J. Allergy Clin. Immunol. 90, 32–42.

    PubMed  CAS  Google Scholar 

  143. Manolitsas, N. D., Wang, J., Devalia, J. L., Trigg, C. I., McAulay, A. E., and Davies, R. J. (1995), Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am. J. Respir. Crit. Care Med. 151, 1925–1930.

    PubMed  CAS  Google Scholar 

  144. Turner, M. O., Johnston, P. R., Pizzichini, E., Pizzichini, M. M. M., Hussack, P. A., and Hargreave, F. E. (1998), Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: A randomized, placebo controlled trial. Can. Respir. J. 5, 261–268.

    PubMed  CAS  Google Scholar 

  145. Gardiner, P. V., Ward, C., Booth, H., Allison, A., Hendrick, D. J., and Walters, E. H. (1994), Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am. J. Respir. Crit. Care Med. 150, 1006–1011.

    PubMed  CAS  Google Scholar 

  146. Kraft, M., Wenzel, S. E., Bettinger, C. M., and Martin, R. J. (1997), The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. Chest 111, 1249–1254.

    PubMed  CAS  Google Scholar 

  147. Roberts, J. A., Bradding, P., Britten, K. M., et al. (1999), The long-acting β2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur. Respir. J. 14, 275–282.

    PubMed  CAS  Google Scholar 

  148. Li, X., Ward, C., Thien, F., et al. (1999), An antiinflammatory effect of salmeterol, a long-acting β2 agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am. J. Respir. Crit. Care Med. 160, 1493–1499.

    PubMed  CAS  Google Scholar 

  149. Lazarus, S. C., Boushey, H. A., Fahy, J. V., et al. (2001), Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 285, 2583–2593.

    PubMed  CAS  Google Scholar 

  150. Boulet, L. P., Chakir, J., Milot, J., Boutet, M., and Laviolette, M. (2001), Effect of salmeterol on allergen-induced airway inflammation in mild allergic asthma. Clin. Exp. Allergy 31, 430–437.

    PubMed  CAS  Google Scholar 

  151. Lindqvist, A., Karjalainen, E. M., Laitinen, L. A., et al. (2003), Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: a randomized, double-blind, parallel group biopsy study comparing the effects of salmeterol, fluticasone propionate, and disodium cromoglycate. J. Allergy Clin. Immunol. 112, 23–28.

    PubMed  CAS  Google Scholar 

  152. Wallin, A., Sandstrom, T., Soderberg, M., et al. (1999), The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma. Am. J. Respir. Crit. Care Med. 159, 79–86.

    PubMed  CAS  Google Scholar 

  153. Overbeek, S. E., Mulder, P. G., Baelemans, S. M., Hoogsteden, H. C., and Prins, J. B. (2005), Formoterol added to low-dose budesonide has no additional antiinflammatory effect in asthmatic patients. Chest 128, 1121–1127.

    PubMed  CAS  Google Scholar 

  154. Haselden, B. M., Kay, A. B., and Larche, M. (1999), Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J. Exp. Med. 189, 1885–1894.

    PubMed  CAS  Google Scholar 

  155. Ali, F. R., Oldfield, W. L., Higashi, N., Larche, M., and Kay, A. B. (2004), Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides. Am. J. Respir. Crit. Care Med. 169, 20–26.

    PubMed  Google Scholar 

  156. Machida, I., Matsuse, H., Kondo, Y., et al. (2005), Effects of various anti-asthmatic agents on mite allergen-pulsed murine bone marrow-derived dendritic cells. Clin. Exp. Allergy 35, 884–888.

    PubMed  CAS  Google Scholar 

  157. Diamant, Z., Timmers, M. C., Van, d., V, Page, C. P., van der Meer, F. J., and Sterk, P. J. (1996), Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am. J. Respir. Crit. Care Med. 153, 1790–1795.

    PubMed  CAS  Google Scholar 

  158. Vancheri, C., Mastruzzo, C., Armato, F., et al. (2001), intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis. J. Allergy Clin. Immunol. 108, 703–708.

    PubMed  CAS  Google Scholar 

  159. Lever, R. and Page, C. P. (2002), Novel drug development opportunities for heparin. Nat. Rev. Drug Discov. 1, 140–148.

    PubMed  CAS  Google Scholar 

  160. Page, C. P. (1991), Inhibition of natural anti-inflammatory mechanism by beta2-agonists [4]. Lancet 337, 1285–1286.

    PubMed  CAS  Google Scholar 

  161. Rauter, I., Krauth, M.-T., Flicker, S., et al. (2005), Allergen cleavage by effector cell-derived proteases regulates allergic inflammation. Int. J. Immunorehab. 7, 30.

    Google Scholar 

  162. Gilbert, I. A., Lenner, K. A., McFadden, E. R. Jr. (1988), Sympathoadrenal response to repetitive exercise in normal and asthmatic subjects. J. Appl. Physiol. 64, 2667–2674.

    PubMed  CAS  Google Scholar 

  163. Bates, M. E., Clayton, M., Calhoun, W., et al. (1994), Relationship of plasma epinephrine and circulating eosinophils to nocturnal asthma. Am. J. Respir Crit Care Med. 149, 667–672.

    PubMed  CAS  Google Scholar 

  164. Swystun, V. A., Gordon, J. R., Davis, E. B., Zhang, X., and Cockcroft, D. W. (2000), Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J. Allergy Clin. Immunol. 106, 57–64.

    PubMed  CAS  Google Scholar 

  165. Penn, R. B., Shaver, J. R., Zangrilli, J. G., et al. (1996), Effects of inflammation and acute beta-agonist inhalation on beta 2-AR signaling in human airways. Am J. Physiol 271, L601-L608.

    PubMed  CAS  Google Scholar 

  166. Waldeck, B. (1999), Enantiomers of bronchodilating beta2-adrenoceptor agonists: Is there a cause for concern? J. Allergy Clin. Immunol. 103, 742–748.

    PubMed  CAS  Google Scholar 

  167. Dhand, R., Goode, M., Reid, R., Fink, J. B., Fahey, P. J., and Tobin, M. J. (1999), Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol. Am. J. Respir. Crit. Care Med. 160, 1136–1141.

    PubMed  CAS  Google Scholar 

  168. Eaton, E. A., Walle, U. K., Wilson, H. M., Aberg, G., and Walle, T. (1996), Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. Br. J. Clin. Pharmacol. 41, 201–206.

    Article  PubMed  CAS  Google Scholar 

  169. Walle, T. and Walle, U. K. (1990), Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol. Br. J. Clin. Pharmacol. 30, 127–133.

    PubMed  CAS  Google Scholar 

  170. Sanjar, S., Kristersson, A., Mazzoni, L., Morley, J., and Schaeublin, E. (1990), Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline. J. Physiol. 425, 43–54.

    PubMed  CAS  Google Scholar 

  171. Mazzoni, L., Naef, R., Chapman, I. D., and Morley, J. (1994), Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of beta 2-selective sympathomimetics. Pulm. Pharmacol. 7, 367–376.

    PubMed  CAS  Google Scholar 

  172. Handley, D. A., McCullough, J. R., Crowther, S. D., and Morley, J. (1998), Sympathomimetic enantiomers and asthma. Chirality 10, 262–272.

    PubMed  CAS  Google Scholar 

  173. Keir, S., Page, C., and Spina, D. (2002), Bronchial hyperresponsiveness induced by chronic treatment with albuterol: Role of sensory nerves. J. Allergy Clin. Immunol. 110, 388–394.

    PubMed  CAS  Google Scholar 

  174. Henderson, W. R. Jr., Banerjee, E. R., and Chi, E. Y. (2005), Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model. J. Allergy Clin. Immunol. 116, 332–340.

    PubMed  CAS  Google Scholar 

  175. Ameredes, B. T. and Calhoun, W. J. (2005), Modulation of GM-CSF release by enantiomers of beta-agonists in human airway smooth muscle. J. Allergy Clin. Immunol. 116, 65–72.

    PubMed  CAS  Google Scholar 

  176. Perrin-Fayolle, M. (1995), Salbutamol in the treatment of asthma. Lancet 346, 1101.

    PubMed  CAS  Google Scholar 

  177. Cockcroft, D. W. (1999), Pharmacologic therapy for asthma: Overview and historical perspective. J. Clin. Pharmacol. 39, 216–222.

    PubMed  CAS  Google Scholar 

  178. Crowther, S. D., Morley, J., and Costello, J. F. (1997), Varied effects of regular salbutamol on airway responsiveness to inhaled spasmogens. Lancet 350, 1450.

    PubMed  CAS  Google Scholar 

  179. Agrawal, D. K., Ariyarathna, K., and Kelbe, P. W. (2004), (S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells. J. Allergy Clin. Immunol. 113, 503–510.

    PubMed  CAS  Google Scholar 

  180. Leff, A. R., Herrnreiter, A., Naclerio, R. M., Barrody, F. M., Handley, D. A., and Munoz, N. M. (1997), Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulmon. Pharmacol. Ther. 10, 97–104.

    CAS  Google Scholar 

  181. Cho, S. H., Hartleroad, J. Y., and Oh, C. K. (2001), (S)-albuterol increases the production of histamine and IL-4 in mast cells. Int. Arch. Allergy Immunol. 124, 478–484.

    PubMed  CAS  Google Scholar 

  182. Abraha, D., Cho, S. H., Agrawal, D. K., Park, J. M., and Oh, C. K. (2004), (S,S)-formoterol increases the production of IL-4 in mast cells and the airways of a murine asthma model. Int. Arch. Allergy Immunol. 133, 380–388.

    PubMed  CAS  Google Scholar 

  183. Baramki, D., Koester, J., Anderson, A. I., and Borish, L. (2002), Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J. Allergy Clin. Immunol. 109, 449–454.

    PubMed  CAS  Google Scholar 

  184. Volcheck, G. W., Kelkar, P., Bartemes, K. R., Gleich, G. J., and Kita, H. (2005), Effects of (R)- and (S)-isomers of beta-adrenergic agonists on eosinophil response to interleukin-5. Clin. Exp. Allergy 35, 1341–1346.

    PubMed  CAS  Google Scholar 

  185. McGraw, D. W., Almoosa, K. F., Paul, R. J., Kobilka, B. K., and Liggett, S. B. (2003), Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox. J. Clin. Invest. 112, 619–626.

    PubMed  CAS  Google Scholar 

  186. Callaerts-Vegh, Z., Evans, K. L., Dudekula, N., et al. (2004), Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc. Natl. Acad. Sci. USA 101, 4948–4953.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sackler Institute of Pulmonary Pharmacology, School of Biomedical and Health Sciences, King's College London, UK

    Clive P. Page & Domenico Spina

Authors
  1. Clive P. Page
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Domenico Spina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clive P. Page.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Page, C.P., Spina, D. β2-Agonists and bronchial hyperresponsiveness. Clinic Rev Allerg Immunol 31, 143–161 (2006). https://doi.org/10.1385/CRIAI:31:2:143

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CRIAI:31:2:143

Index Entries

Search

Navigation